SCHEMBL7098191

SCHEMBL7098191

Cc1cc(-c2c(O)c(C)c(-c3cccnc3)oc2=O)c(Cl)cc1-c1ccc(F)cc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.41
RPS6KA3 P51812 1/20 0.39
KCNA3 P22001 1/20 0.37
ROS1 P08922 1/20 0.36
MAOB P27338 1/20 0.36
CYP17A1 P05093 2/20 0.36
SQOR Q9Y6N5 1/20 0.36
SLC2A1 P11166 1/20 0.35
KDM4E B2RXH2 2/20 0.35
PDE3B Q13370 1/20 0.35
PDE3A Q14432 1/20 0.35
ACLY P53396 2/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6208131 0.89 CYP17A1 (0.39) MAOARPS6KA3KCNA3ROS1MAOB
SCHEMBL810958 0.89 CYP17A1 (0.41) MAOARPS6KA3ROS1MAOBCYP17A1
SCHEMBL812046 0.76 NPC1 (0.41) MAOAKCNA3MAOBKDM4EPDE3B
SCHEMBL6558583 0.74 PTGS2 (0.39) MAOAMAOBKDM4EALDH1A1GAA
SCHEMBL6558585 0.73 ESR1 (0.45) KDM4EPDE3BPDE3AALDH1A1GAA
SCHEMBL3176584 0.73 MAOA (0.41) MAOAKCNA3MAOBKDM4EPDE3B
SCHEMBL5232820 0.73 MAOA (0.48) MAOAKCNA3MAOBKDM4EACLY
SCHEMBL811879 0.73 CYP17A1 (0.36) MAOAROS1MAOBCYP17A1SQOR
SCHEMBL1812246 0.72 MAOB (0.41) MAOAMAOBCYP17A1KDM4EACLY
SCHEMBL2434431 0.70 MAOA (0.43) MAOAKCNA3MAOBPDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030096806-A1 Arylphenyl-substituted cyclic ketoenols LIEB FOLKER (DE) 2003-05-22 US disclosed
US-6451843-B1 Arylphenyl-substituted cyclic keto enols BAYER AKTIENGESELLSCHAFT (DE) 2002-09-17 US disclosed
EP-1075465-A1 ARYLPHENYL-SUBSTITUTED CYCLIC KETO ENOLS BAYER AG (DE) 2001-02-14 EP disclosed
WO-1999055673-A1 ARYLPHENYL-SUBSTITUTED CYCLIC KETO ENOLS BAYER AKTIENGESELLSCHAFT (DE) 1999-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096806-A1 Arylphenyl-substituted cyclic ketoenols KCNE1, KCNQ3, SULT1E1 MAOA 2242/4885RPS6KA3 2283/4885KCNA3 15/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.